XML 27 R34.htm IDEA: XBRL DOCUMENT v2.4.0.8
Share-Based Plans (Details) (USD $)
3 Months Ended 6 Months Ended
Aug. 03, 2013
May 04, 2013
Jul. 28, 2012
Aug. 03, 2013
Jul. 28, 2012
Feb. 02, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Allocated Share-based Compensation Expense $ 3,200,000   $ 6,600,000 $ 7,800,000 $ 14,700,000  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]            
Weighted-average fair value of stock options granted $ 11.87   $ 13.48 $ 12.10 $ 14.23  
Risk-free interest rate 0.70%   0.50% 0.70% 0.60%  
Expected life (years) 4 years 2 months 12 days   4 years 2 months 12 days 4 years 2 months 12 days 4 years 2 months 12 days  
Expected volatility 41.10%   43.40% 42.30% 41.00%  
Expected annual forfeiture rate 3.00%   3.00% 3.00% 3.00%  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]            
Outstanding stock options 3,745,991 3,029,086   3,029,086    
Options, Grants in Period, Net of Forfeitures 164,750 851,000        
Options, Exercises in Period (70,400) (55,420)        
Options, Forfeitures and Expirations in Period (233,650) (78,675)        
Outstanding stock options 3,606,691 3,745,991   3,606,691    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]            
Options, Vested and Expected to Vest, Outstanding, Number 3,443,036     3,443,036    
Options, Exercisable, Number 1,669,689     1,669,689    
Options, Outstanding, Weighted Average Exercise Price $ 34.96 $ 34.97   $ 34.96   $ 34.49
Options, Grants in Period, Weighted Average Exercise Price $ 35.94 $ 35.72        
Options, Exercises in Period, Weighted Average Exercise Price $ 24.45 $ 16.24        
Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price $ 39.03 $ 37.72        
Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $ 34.77     $ 34.77    
Options, Exercisable, Weighted Average Exercise Price $ 30.66     $ 30.66    
Options, Outstanding, Weighted Average Remaining Contractual Term 4 years 8 months 13 days 4 years 9 months 17 days        
Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term 4 years 7 months 6 days          
Options, Exercisable, Weighted Average Remaining Contractual Term 3 years 4 months 24 days          
Options, Outstanding, Intrinsic Value 13,814,000 15,650,000   13,814,000    
Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value 13,730,000     13,730,000    
Options, Exercisable, Intrinsic Value 12,743,000     12,743,000    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]            
Nonvested, beginning balance 874,809 783,609   783,609    
Grants in Period 110,251 339,500        
Vested in Period (39,784) 0        
Forfeited in Period (138,300) (248,300)        
Nonvested, ending balance 806,976 874,809   806,976    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]            
Nonvested, Weighted Average Grant Date Fair Value $ 38.64 $ 39.22   $ 38.64   $ 42.25
Grants in Period, Weighted Average Grant Date Fair Value $ 35.09 $ 35.54        
Vested in Period, Weighted Average Grant Date Fair Value $ 35.70 $ 0.00        
Forfeited in Period, Weighted Average Grant Date Fair Value $ 40.28 $ 43.75        
Total intrinsic value of stock options exercised 749,000   953,000 1,789,000 29,075,000  
Total fair value of restricted stock vested 1,434,000   804,000 1,434,000 21,907,000  
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized 43,300,000     43,300,000    
Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition 2 years 1 month 6 days          
Restricted Stock [Member]
           
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]            
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period       5 years    
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period       3 years    
Restricted Stock [Member] | Nonemployee Board of Directors [Member]
           
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Deferred Compensation Arrangement, Fair Value of Shares Issued to Each Director $ 100,000          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]            
Vested in Period (20,784)          
Stock Options [Member]
           
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]            
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period       4 years    
Share Based Compensation Arrangement By Share Based Payment Award, Award Expiration Period From Grant Date       7 years    
Performance Shares [Member]
           
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]            
Share Based Compensation Arrangement By Share Based Payment Award, Award Expiration Period From Grant Date       7 years    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]            
Grants in Period 37,800